{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:39:57Z","timestamp":1792643997066,"version":"4.5.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007688","name":"American University of Beirut","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007688","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejmech.2026.119355","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:43:45Z","timestamp":1790135025000},"page":"119355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development of Imiqualine compounds with enhanced activity against cutaneous leishmaniasis"],"prefix":"10.1016","volume":"320","author":[{"given":"Sana","family":"El-Sayyed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Patinote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maguy","family":"Hamie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israa","family":"El Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9117-8773","authenticated-orcid":false,"given":"Jessica","family":"Saliba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Paniagua-Gayraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adib","family":"Charafeddine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1516-9090","authenticated-orcid":false,"given":"Nour","family":"Bou Karroum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehan","family":"Wegrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9221-4466","authenticated-orcid":false,"given":"Dalia","family":"Ibarissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Tisnerat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Antoine","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Deleuze-Masqu\u00e9fa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1069-0477","authenticated-orcid":false,"given":"Hiba","family":"El Hajj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejmech.2026.119355_bib1","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s40257-022-00726-8","article-title":"Cutaneous leishmaniasis: a 2022 updated narrative review into diagnosis and management developments","volume":"23","author":"de Vries","year":"2022","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.ejmech.2026.119355_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2024.01.010","article-title":"Control, elimination, and eradication efforts for neglected tropical diseases in the world health organization African region over the last 30 years: a scoping review","volume":"141","author":"Wolfe","year":"2024","journal-title":"Int. J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119355_bib3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/bjd\/ljac031","article-title":"World health organization strategic framework for integrated control and management of skin-related neglected tropical diseases: what does this mean for dermatologists?","volume":"188","author":"Yotsu","year":"2023","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejmech.2026.119355_bib4","article-title":"Cutaneous leishmaniasis: epidemiology, treatment access and translational challenges of topical therapies","volume":"16","author":"Carrer","year":"2025","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119355_bib5","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1186\/s12879-019-4506-1","article-title":"Cutaneous leishmaniasis a neglected tropical disease: community knowledge, attitude and practices in an endemic area, northwest Ethiopia","volume":"19","author":"Tamiru","year":"2019","journal-title":"BMC Infect. Dis."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119355_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/tropicalmed8050275","article-title":"Alternative non-drug treatment options of the Most neglected parasitic disease cutaneous leishmaniasis: a narrative review","volume":"8","author":"Orabi","year":"2023","journal-title":"Trop. Med. Infect. Dis."},{"issue":"10","key":"10.1016\/j.ejmech.2026.119355_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/tropicalmed8100465","article-title":"Entomological survey and leishmania (Leishmania) mexicana prevalence in sand fly species during an outbreak of cutaneous leishmaniasis in Quintana Roo state, Mexico","volume":"8","author":"Caneda-Guzman","year":"2023","journal-title":"Trop. Med. Infect. Dis."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119355_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007092","article-title":"Cutaneous leishmaniasis and co-morbid major depressive disorder: a systematic review with burden estimates","volume":"13","author":"Bailey","year":"2019","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"10","key":"10.1016\/j.ejmech.2026.119355_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006914","article-title":"Uncharted territory of the epidemiological burden of cutaneous leishmaniasis in sub-Saharan Africa-A systematic review","volume":"12","author":"Sunyoto","year":"2018","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119355_bib10","first-page":"544","article-title":"Clinical features of anthroponotic cutaneous leishmaniasis in a major focus, Southeastern Iran, 1994-2014","volume":"12","author":"Khosravi","year":"2017","journal-title":"Iran. J. Parasitol."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119355_bib11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2567.2009.03223.x","article-title":"Evaluation of localized and systemic immune responses in cutaneous leishmaniasis caused by Leishmania tropica: interleukin-8, monocyte chemotactic protein-1 and nitric oxide are major regulatory factors","volume":"130","author":"Kumar","year":"2010","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.ejmech.2026.119355_bib12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1574-695X.2009.00607.x","article-title":"Correlation of parasitic load with interleukin-4 response in patients with cutaneous leishmaniasis due to Leishmania tropica","volume":"57","author":"Kumar","year":"2009","journal-title":"FEMS Immunol. Med. Microbiol."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119355_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01393-17","article-title":"Gene expression in Leishmania is regulated predominantly by gene dosage","volume":"8","author":"Iantorno","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.ejmech.2026.119355_bib14","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.meegid.2017.02.003","article-title":"RNA-seq in kinetoplastids: a powerful tool for the understanding of the biology and host-pathogen interactions","volume":"49","author":"Patino","year":"2017","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.ejmech.2026.119355_bib15","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3389\/fcimb.2018.00326","article-title":"In search of biomarkers for pathogenesis and control of leishmaniasis by global analyses of leishmania-infected macrophages","volume":"8","author":"Veras","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119355_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0012085","article-title":"Transcriptional signatures in human macrophage-like cells infected by Leishmania infantum, Leishmania major and Leishmania tropica","volume":"18","author":"Diotallevi","year":"2024","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119355_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010518","article-title":"In vivo transcriptional analysis of mice infected with Leishmania major unveils cellular heterogeneity and altered transcriptomic profiling at single-cell resolution","volume":"16","author":"Venugopal","year":"2022","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2026.119355_bib18","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.actatropica.2017.08.016","article-title":"Leishmania tropica infected human lesions: whole genome transcription profiling","volume":"176","author":"Masoudzadeh","year":"2017","journal-title":"Acta Trop."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119355_bib19","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1124\/mol.105.019281","article-title":"Antimony-based antileishmanial compounds prolong the cardiac action potential by an increase in cardiac calcium currents","volume":"69","author":"Kuryshev","year":"2006","journal-title":"Mol. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119355_bib20","article-title":"Challenges in diagnosing biopsy-negative cutaneous leishmaniasis and role of systemic therapies","volume":"17","author":"Rafique","year":"2025","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.ejmech.2026.119355_bib21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4103\/0974-777X.62886","article-title":"Liposomal amphotericin B and leishmaniasis: dose and response","volume":"2","author":"Sundar","year":"2010","journal-title":"J. Global Infect. Dis."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119355_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15010099","article-title":"Liposomal Amphotericin B for treatment of leishmaniasis: from the identification of critical physicochemical attributes to the design of effective topical and oral formulations","volume":"15","author":"Fr\u00e9zard","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejmech.2026.119355_bib23","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.actatropica.2018.03.016","article-title":"Liposomal amphotericin B treatment of old World cutaneous and mucosal leishmaniasis: a literature review","volume":"182","author":"Mosimann","year":"2018","journal-title":"Acta Trop."},{"key":"10.1016\/j.ejmech.2026.119355_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fitd.2022.837460","article-title":"Tackling drug resistance and other causes of treatment failure in leishmaniasis","volume":"3","author":"Wijnant","year":"2022","journal-title":"Front. Trop. Dis."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119355_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006854","article-title":"EAPB0503: an Imiquimod analog with potent in vitro activity against cutaneous leishmaniasis caused by Leishmania major and Leishmania tropica","volume":"12","author":"El Hajj","year":"2018","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"8","key":"10.1016\/j.ejmech.2026.119355_bib26","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.1365-4632.2008.04010.x","article-title":"Tropical medicine rounds: treatment of old world cutaneous leishmaniasis with dapsone, itraconazole, cryotherapy, and imiquimod, alone and in combination","volume":"48","author":"Al-Mutairi","year":"2009","journal-title":"Int. J. Dermatol."},{"issue":"12","key":"10.1016\/j.ejmech.2026.119355_bib27","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1086\/518172","article-title":"Role of imiquimod and parenteral meglumine antimoniate in the initial treatment of cutaneous leishmaniasis","volume":"44","author":"Arevalo","year":"2007","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119355_bib28","article-title":"Evaluating the efficacy of combined intralesional sodium stibogluconate plus topical imiquimod on healing and risk of scarring of cutaneous leishmaniasis: a case-control study","volume":"14","author":"Dhaher","year":"2022","journal-title":"Cureus"},{"issue":"12","key":"10.1016\/j.ejmech.2026.119355_bib29","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/archderm.142.12.1575","article-title":"Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis: a randomized assessor-blind controlled trial","volume":"142","author":"Firooz","year":"2006","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.ejmech.2026.119355_bib30","doi-asserted-by":"crossref","first-page":"e0305","DOI":"10.1590\/0037-8682-0305-2020","article-title":"Efficacy of imiquimod 5% cream as first-line management in cutaneous leishmaniasis caused by Leishmania mexicana","volume":"54","author":"Fuentes-Nava","year":"2021","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.ejmech.2026.119355_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2023.213350","article-title":"Corrigendum to 'Mannosylated imiquimod-terbinafine co-loaded transethosomes for cutaneous leishmaniasis; assessment of its anti-leishmanial potential, in vivo safety and immune response modulation'","volume":"148","author":"Jamshaid","year":"2023","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.ejmech.2026.119355_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.meegid.2019.01.005","article-title":"Protection induced by Leishmania major antigens and the imiquimod adjuvant encapsulated on liposomes in experimental cutaneous leishmaniasis","volume":"70","author":"Mehravaran","year":"2019","journal-title":"Infect. Genet. Evol."},{"issue":"10","key":"10.1016\/j.ejmech.2026.119355_bib33","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1086\/429238","article-title":"Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru","volume":"40","author":"Miranda-Ver\u00e1stegui","year":"2005","journal-title":"Clin. Infect. Dis."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119355_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000491","article-title":"First-line therapy for human cutaneous leishmaniasis in Peru using the TLR7 agonist imiquimod in combination with pentavalent antimony","volume":"3","author":"Miranda-Verastegui","year":"2009","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119355_bib35","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1046\/j.1365-4362.2003.01955.x","article-title":"Transient effect of topical treatment of cutaneous leishmaniasis with imiquimod","volume":"42","author":"Seeberger","year":"2003","journal-title":"Int. J. Dermatol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119355_bib36","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.jaad.2016.08.040","article-title":"Leishmania tropica: combined debulking and imiquimod for the treatment of nonresponsive cutaneous leishmaniasis","volume":"76","author":"Taylor","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119355_bib37","first-page":"178","article-title":"Evaluating the effects of imiquimod on paths of TLRs and inflammatory cytokines signaling in infected macrophages with Leishmania major in vitro and in vivo","volume":"20","author":"Ebrahimisadr","year":"2025","journal-title":"Iran. J. Parasitol."},{"key":"10.1016\/j.ejmech.2026.119355_bib38","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.ejmech.2017.07.021","article-title":"Imidazo[1,2-a]pyrazine, Imidazo[1,5-a]quinoxaline and Pyrazolo[1,5-a]quinoxaline derivatives as IKK1 and IKK2 inhibitors","volume":"138","author":"Patinote","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"15","key":"10.1016\/j.ejmech.2026.119355_bib39","doi-asserted-by":"crossref","first-page":"7015","DOI":"10.1021\/acs.jmedchem.9b00411","article-title":"Novel and selective TLR7 antagonists among the Imidazo[1,2-a]pyrazines, Imidazo[1,5-a]quinoxalines, and Pyrazolo[1,5-a]quinoxalines series","volume":"62","author":"Bou Karroum","year":"2019","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119355_bib40","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1016\/j.ejmech.2009.02.007","article-title":"New imidazo[1,2-a]quinoxaline derivatives: synthesis and in vitro activity against human melanoma","volume":"44","author":"Deleuze-Masquefa","year":"2009","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119355_bib41","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.bmc.2016.04.004","article-title":"New imidazoquinoxaline derivatives: synthesis, biological evaluation on melanoma, effect on tubulin polymerization and structure-activity relationships","volume":"24","author":"Zghaib","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119355_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113031","article-title":"Imidazo[1,2-a]quinoxalines for melanoma treatment with original mechanism of action","volume":"212","author":"Patinote","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119355_bib43","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41419-025-07747-1","article-title":"Inhibiting microtubule polymerization with EAPB02303, a prodrug activated by catechol-O-methyl transferase, enhances paclitaxel effect in pancreatic cancer models","volume":"16","author":"Bigot","year":"2025","journal-title":"Cell Death Dis."},{"issue":"14","key":"10.1016\/j.ejmech.2026.119355_bib44","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.3390\/molecules28145478","article-title":"[1,2,4]triazolo[4,3-a]quinoxaline as novel scaffold in the imiqualines family: candidates with cytotoxic activities on melanoma cell lines","volume":"28","author":"Patinote","year":"2023","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119355_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-72671-7","article-title":"Molecular signatures of anthroponotic cutaneous leishmaniasis in the lesions of patients infected with Leishmania tropica","volume":"10","author":"Masoudzadeh","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119355_bib46","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0223-5234(01)01213-2","article-title":"Imidazo[1,2-a]quinoxalines: synthesis and cyclic nucleotide phosphodiesterase inhibitory activity","volume":"36","author":"Parra","year":"2001","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119355_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.629917","article-title":"Imiquimod targets toxoplasmosis through modulating host toll-like Receptor-MyD88 signaling","volume":"12","author":"Hamie","year":"2021","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119355_bib48","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"issue":"41","key":"10.1016\/j.ejmech.2026.119355_bib49","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.3748\/wjg.v19.i41.7121","article-title":"Reference genes for quantitative RT-PCR data in gastric tissues and cell lines","volume":"19","author":"Wisnieski","year":"2013","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119355_bib50","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1600-0560.2011.01861.x","article-title":"Molecular diagnosis of cutaneous leishmaniasis and species identification: analysis of 122 biopsies with varied parasite index","volume":"39","author":"Yehia","year":"2012","journal-title":"J. Cutan. Pathol."},{"issue":"8","key":"10.1016\/j.ejmech.2026.119355_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1013427","article-title":"Transcriptome profiling of L. infantum-infected human macrophages reveals sex-specific type I interferon induction","volume":"21","author":"Bea","year":"2025","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2026.119355_bib52","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fimmu.2018.00130","article-title":"Genetic regulation of guanylate-binding proteins 2b and 5 during leishmaniasis in mice","volume":"9","author":"Sohrabi","year":"2018","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.ejmech.2026.119355_bib53","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202402016","article-title":"LYSMD proteins promote activation of Rab32-family GTPases for lysosome-related organelle biogenesis","volume":"223","author":"Li","year":"2024","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.119355_bib54","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2180-12-22","article-title":"A comparison of two distinct murine macrophage gene expression profiles in response to Leishmania amazonensis infection","volume":"12","author":"Probst","year":"2012","journal-title":"BMC Microbiol."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119355_bib55","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/PAI.0000000000000626","article-title":"Hematoxylin and eosin counterstaining protocol for immunohistochemistry interpretation and diagnosis","volume":"27","author":"Grosset","year":"2019","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.ejmech.2026.119355_bib56","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.actatropica.2017.08.016","article-title":"Leishmania tropica infected human lesions: whole genome transcription profiling","volume":"176","author":"Nasrin Masoudzadeh","year":"2017","journal-title":"Acta Trop."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119355_bib57","doi-asserted-by":"crossref","first-page":"16198","DOI":"10.1038\/s41598-020-72671-7","article-title":"Harandi Molecular signatures of anthroponotic cutaneous leishmaniasis in the lesions of patients infected with Leishmania tropica","volume":"10","author":"Nasrin Masoudzadeh","year":"2020","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119355_bib58","doi-asserted-by":"crossref","first-page":"e0012085","DOI":"10.1371\/journal.pntd.0012085","article-title":"Transcriptional signatures in human macrophage-like cells infected by Leishmania infantum, Leishmania major and Leishmania tropica","volume":"18","author":"Aurora Diotallevi","year":"2024","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"18","key":"10.1016\/j.ejmech.2026.119355_bib59","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1021\/jm00096a008","article-title":"Synthesis and antibronchospastic activity of 8-alkoxy-and 8-(alkylamino) imidazo [1, 2-a] pyrazines","volume":"35","author":"Bonnet","year":"1992","journal-title":"J. Med. Chem."},{"issue":"41","key":"10.1016\/j.ejmech.2026.119355_bib60","doi-asserted-by":"crossref","first-page":"6536","DOI":"10.1016\/j.tet.2016.08.067","article-title":"Novel multi-component synthesis of 1, 4-disubstituted pyrrolo [1, 2-a] quinoxalines through palladium-catalyzed coupling reaction\/hetero-annulation in water","volume":"72","author":"Keivanloo","year":"2016","journal-title":"Tetrahedron"},{"issue":"9","key":"10.1016\/j.ejmech.2026.119355_bib61","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nri.2016.72","article-title":"Cutaneous leishmaniasis: immune responses in protection and pathogenesis","volume":"16","author":"Scott","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119355_bib62","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s42003-022-03240-z","article-title":"Sand flies: basic information on the vectors of leishmaniasis and their interactions with Leishmania parasites","volume":"5","author":"Cec\u00edlio","year":"2022","journal-title":"Commun. Biol."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119355_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.ejmech.2026.119355_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003208","article-title":"Leishmaniasis in the middle East: incidence and epidemiology","volume":"8","author":"Salam","year":"2014","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119355_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010665","article-title":"Review of the neglected tropical diseases programme implementation during 2012-2019 in the WHO-Eastern Mediterranean Region","volume":"16","author":"Warusavithana","year":"2022","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"10","key":"10.1016\/j.ejmech.2026.119355_bib66","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.3201\/eid2010.140288","article-title":"Ongoing epidemic of cutaneous leishmaniasis among Syrian refugees, Lebanon","volume":"20","author":"Saroufim","year":"2014","journal-title":"Emerg. Infect. Dis."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119355_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008684","article-title":"Expanded genome-wide comparisons give novel insights into population structure and genetic heterogeneity of Leishmania tropica complex","volume":"14","author":"Salloum","year":"2020","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119355_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00436-008-0943-2","article-title":"Leishmaniasis treatment--a challenge that remains: a review","volume":"103","author":"Santos","year":"2008","journal-title":"Parasitol. Res."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119355_bib69","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1186\/s12879-025-11229-2","article-title":"Molecular detection of Leishmania major human infections in the Zinder area, niger","volume":"25","author":"Blaizot","year":"2025","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119355_bib70","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s13071-024-06381-8","article-title":"Cutaneous leishmaniasis in Sub-Saharan Africa: a systematic review of Leishmania species, vectors and reservoirs","volume":"17","author":"Blaizot","year":"2024","journal-title":"Parasites Vectors"},{"issue":"9","key":"10.1016\/j.ejmech.2026.119355_bib71","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1128\/AAC.38.9.2059","article-title":"Posttherapy suppression of genital herpes simplex virus (HSV) recurrences and enhancement of HSV-specific T-cell memory by imiquimod in Guinea pigs","volume":"38","author":"Harrison","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119355_bib72","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1086\/314782","article-title":"Treatment of experimental leishmaniasis with the immunomodulators imiquimod and S-28463: efficacy and mode of action","volume":"179","author":"Buates","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.119355_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2022.213266","article-title":"Mannosylated imiquimod-terbinafine co-loaded transethosomes for cutaneous leishmaniasis; assessment of its anti-leishmanial potential, in vivo safety and immune response modulation","volume":"145","author":"Jamshaid","year":"2023","journal-title":"Biomater. Adv."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119355_bib74","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00323-25","article-title":"Dual immunomodulatory and antileishmanial potential of TLR7\/8 agonists against Leishmania donovani","volume":"93","author":"Thakur","year":"2025","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119355_bib75","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2217\/17460913.4.2.241","article-title":"Tracing immunity to human leishmaniasis","volume":"4","author":"Nyl\u00e9n","year":"2009","journal-title":"Future Microbiol."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119355_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000648","article-title":"Delineation of diverse macrophage activation programs in response to intracellular parasites and cytokines","volume":"4","author":"Zhang","year":"2010","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2026.119355_bib77","series-title":"Guanylate-Binding Proteins Promote Host Defense Against Leishmania major by Balancing iNOS\/Arg-1 in Myeloid Cells","author":"Fry","year":"2025"},{"key":"10.1016\/j.ejmech.2026.119355_bib78","article-title":"HIF-alpha signaling regulates the macrophage inflammatory response during Leishmania major infection","author":"Fry","year":"2024","journal-title":"bioRxiv"},{"issue":"2","key":"10.1016\/j.ejmech.2026.119355_bib79","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1128\/CMR.18.2.293-305.2005","article-title":"Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view","volume":"18","author":"Olivier","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2026.119355_bib80","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.3389\/fmicb.2017.02682","article-title":"Arginine and polyamines fate in Leishmania infection","volume":"8","author":"Muxel","year":"2017","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119355_bib81","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s13071-025-07004-6","article-title":"Leptin enhances the efficacy of glucantime to modulate macrophage polarization toward the M1 phenotype in Leishmania tropica-infected macrophages","volume":"18","author":"Keyhani","year":"2025","journal-title":"Parasites Vectors"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426008007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426008007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:19:55Z","timestamp":1792642795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426008007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":81,"alternative-id":["S0223523426008007"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119355","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of Imiqualine compounds with enhanced activity against cutaneous leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119355","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119355"}}